Skip to main content
Clinical Trials/NCT04355923
NCT04355923CompletedNot Applicable

Impact of Confinement on the Treatment of Spondyloarthritis.

Centre Hospitalier Universitaire de Nice2 sites in 1 country1,000 target enrollmentStarted: April 20, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,000
Locations
2
Primary Endpoint
treatment use

Study Overview

Brief Summary

Evaluate the impact of confinement on treatment use in spondyloarthritis. Study hypothesis that with the confinement, subjects will stop their treatment. The main objective is to study the impact of confinement on treatment. And secondly to look for for specific psychological profile linked to the interruption of the treatment. the study population consists of patients with spondyloarthritis and belonging to a patient association (ACS). All patients over 18 are included. A mailing questionnaire will be send to all patients. data on diseases activity and treatment will be collected

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • spondyloarthritis,
  • age over 18 ans
  • treatment by NSAID or biological treatment to be part of the patient association "ACS" (action contre les spondylarthropathies).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

treatment use

Time Frame: 1 month

treatment continuation

Secondary Outcomes

  • activity of disease(1 week)
  • psychological aspects(1 month)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials